WALTHAM, Mass.--(BUSINESS WIRE)--Quantia, Inc.—the platform for Physician Engagement—today announced key findings from its new report, “Reading the Signs: A Roadmap for Increasing Physician Engagement in the Biosimilars Market.” The report examines healthcare professionals’ awareness of biosimilar drugs, potential barriers to adoption, and opportunities to provide education that may drive prescribing decisions. Key findings from this report include: 94% of physician respondents believe biosimil
| < Prev | Next > |
|---|
